RSVP for Sept 19 Congressional Briefing on Regenerative Cell Therapies

Regenerative cellular therapies represent the next generation of groundbreaking treatments that are showing great promise in cardiology, neurology, oncology, orthopedics, ophthalmology, and other areas. Several well-designed clinical trials are now underway. At the same time, a handful of clinics have caused patient harm or made questionable claims, taking advantage of vulnerable patients and casting negative light on this emerging science and industry. The 21st Century Cures Act contained several provisions to make safe and effective regenerative cellular therapies available to patients, including extending FDA expedited programs and providing funds for research through the NIH.

Join us for a discussion on regenerative cell therapies, including promising research for diseases for which there is no cure, the importance of cell characterization and quality controls in manufacturing, and the actions that the FDA is taking to both advance and support the science and address “bad actors”.